A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

10.1186/s12885-015-1957-7

Saved in:

Bibliographic Details
Main Authors:	Seibold, P, Schmezer, P, Behrens, S
Other Authors:	SURGERY
Format:	Article
Published:	2020
Subjects:	anthracycline guanine nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 2 antineoplastic agent nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase PARP2 protein, human adult aged Article breast cancer cancer adjuvant therapy cancer patient cancer prognosis cancer radiotherapy cancer specific survival controlled study excision repair female gene frequency gene replication genetic association genetic variability heterozygote human major clinical study middle aged patient assessment postmenopause single nucleotide polymorphism adjuvant chemotherapy Breast Neoplasms genetics genotype meta analysis mortality prognosis proportional hazards model radiotherapy Aged Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Female Genotype Humans Middle Aged Poly(ADP-ribose) Polymerases Polymorphism, Single Nucleotide Postmenopause Prognosis Proportional Hazards Models Radiotherapy
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181408
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-181408
record_format	dspace
spelling	sg-nus-scholar.10635-1814082024-04-25T02:37:43Z A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients Seibold, P Schmezer, P Behrens, S SURGERY anthracycline guanine nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 2 antineoplastic agent nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase PARP2 protein, human adult aged Article breast cancer cancer adjuvant therapy cancer patient cancer prognosis cancer radiotherapy cancer specific survival controlled study excision repair female gene frequency gene replication genetic association genetic variability heterozygote human major clinical study middle aged patient assessment postmenopause single nucleotide polymorphism adjuvant chemotherapy Breast Neoplasms genetics genotype meta analysis mortality postmenopause prognosis proportional hazards model radiotherapy single nucleotide polymorphism Aged Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Chemotherapy, Adjuvant Female Genotype Humans Middle Aged Poly(ADP-ribose) Polymerases Polymorphism, Single Nucleotide Postmenopause Prognosis Proportional Hazards Models Radiotherapy 10.1186/s12885-015-1957-7 BMC Cancer 15 1 978 2020-10-27T10:50:04Z 2020-10-27T10:50:04Z 2015 Article Seibold, P, Schmezer, P, Behrens, S (2015). A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients. BMC Cancer 15 (1) : 978. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-015-1957-7 14712407 https://scholarbank.nus.edu.sg/handle/10635/181408 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	anthracycline guanine nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 2 antineoplastic agent nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase PARP2 protein, human adult aged Article breast cancer cancer adjuvant therapy cancer patient cancer prognosis cancer radiotherapy cancer specific survival controlled study excision repair female gene frequency gene replication genetic association genetic variability heterozygote human major clinical study middle aged patient assessment postmenopause single nucleotide polymorphism adjuvant chemotherapy Breast Neoplasms genetics genotype meta analysis mortality postmenopause prognosis proportional hazards model radiotherapy single nucleotide polymorphism Aged Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Chemotherapy, Adjuvant Female Genotype Humans Middle Aged Poly(ADP-ribose) Polymerases Polymorphism, Single Nucleotide Postmenopause Prognosis Proportional Hazards Models Radiotherapy
spellingShingle	anthracycline guanine nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 2 antineoplastic agent nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase PARP2 protein, human adult aged Article breast cancer cancer adjuvant therapy cancer patient cancer prognosis cancer radiotherapy cancer specific survival controlled study excision repair female gene frequency gene replication genetic association genetic variability heterozygote human major clinical study middle aged patient assessment postmenopause single nucleotide polymorphism adjuvant chemotherapy Breast Neoplasms genetics genotype meta analysis mortality postmenopause prognosis proportional hazards model radiotherapy single nucleotide polymorphism Aged Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Chemotherapy, Adjuvant Female Genotype Humans Middle Aged Poly(ADP-ribose) Polymerases Polymorphism, Single Nucleotide Postmenopause Prognosis Proportional Hazards Models Radiotherapy Seibold, P Schmezer, P Behrens, S A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
description	10.1186/s12885-015-1957-7
author2	SURGERY
author_facet	SURGERY Seibold, P Schmezer, P Behrens, S
format	Article
author	Seibold, P Schmezer, P Behrens, S
author_sort	Seibold, P
title	A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
title_short	A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
title_full	A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
title_fullStr	A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
title_full_unstemmed	A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
title_sort	polymorphism in the base excision repair gene parp2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/181408
_version_	1800914636059443200

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

Similar Items